Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1863468 | 0.81 | — | — | |
| SCHEMBL245997 | 0.81 | — | — | |
| SCHEMBL776242 | 0.80 | CA2 (0.40) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL31726702 | 0.80 | — | — | |
| SCHEMBL16199284 | 0.79 | CA2 (0.38) | CA2CA1CA7CA13KDM4E | |
| SCHEMBL14827735 | 0.79 | KDM4E (0.33) | CA2CA1CA7CA13KDM4E | |
| SCHEMBL777456 | 0.78 | CA2 (0.50) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL22068910 | 0.77 | — | — | |
| SCHEMBL8719789 | 0.76 | CA2 (0.42) | CA2CA1CA7CA13KDM4E | |
| SCHEMBL14827734 | 0.76 | KDM4E (0.31) | CA2CA1CA7CA13KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 469 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024114190-A1 | ELECTROLYTE COMPOSITION, METHOD FOR SECONDARY ELECTROLYTE FILLING, AND LITHIUM SECONDARY BATTERY | 九江天赐高新材料有限公司 | 2024-06-06 | — | — | WO | claimed |
| EP-3072178-B1 | USE OF LITHIUM BIS(FLUOROSULFONYL) IMIDE (LIFSI) IN NON-AQUEOUS ELECTROLYTE SOLUTIONS FOR USE WITH 4.2V AND HIGHER CATHODE MATERIALS FOR LITHIUM ION BATTERIES | SHENZHEN CAPCHEM TECHNOLOGY CO LTD (CN) | 2019-04-10 | — | — | EP | claimed |
| US-9698447-B2 | Use of lithium bis(fluorosulfonyl) imide (LiFSI) in non-aqueous electrolyte solutions for use with 4.2v and higher cathode materials for lithium ion batteries | BASF CORPORATION (US) | 2017-07-04 | — | — | US | claimed |
| EP-3072178-A1 | USE OF LITHIUM BIS(FLUOROSULFONYL) IMIDE (LIFSI) IN NON-AQUEOUS ELECTROLYTE SOLUTIONS FOR USE WITH 4.2V AND HIGHER CATHODE MATERIALS FOR LITHIUM ION BATTERIES | BASF Corporation (US) | 2016-09-28 | — | — | EP | claimed |
| US-20150140446-A1 | Use Of Lithium Bis(Fluorosulfonyl) Imide (LIFSI) In Non-Aqueous Electrolyte Solutions For Use With 4.2v And Higher Cathode Materials For Lithium Ion Batteries | BASF CORPORATION (US) | 2015-05-21 | — | — | US | claimed |
| US-8764853-B2 | Non-aqueous electrolytic solutions and electrochemical cells comprising the same | BASF CORPORATION (US) | 2014-07-01 | — | — | US | claimed |
| US-8715865-B2 | Non-aqueous electrolytic solutions and electrochemical cells comprising the same | BASF CORPORATION (US) | 2014-05-06 | — | — | US | claimed |
| US-20130167363-A1 | Non-aqueous Electrolytic Solutions And Electrochemical Cells Comprising The Same | Novolyte Technologies, Inc. (US) | 2013-07-04 | — | — | US | claimed |
| JP-2010533359-A | — | — | 2010-10-21 | — | — | JP | claimed |
| EP-2183809-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTIONS AND ELECTROCHEMICAL CELLS COMPRISING THE SAME | Novolyte Technologies Inc. (US) | 2010-05-12 | — | — | EP | claimed |
| US-20090017386-A1 | Non-Aqueous Electrolytic Solutions And Electrochemical Cells Comprising The Same | FERRO CORPORATION (US) | 2009-01-15 | — | — | US | claimed |
| WO-2009009251-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTIONS AND ELECTROCHEMICAL CELLS COMPRISING THE SAME | FERRO CORPORATION (US) | 2009-01-15 | — | — | WO | claimed |
| CN-115458808-B | Method for producing lithium fluorosulfonate, nonaqueous electrolyte solution, and nonaqueous electrolyte secondary battery | 三菱化学株式会社 | 2026-05-15 | — | — | CN | disclosed |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | DAIKIN INDUSTRIES, LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| US-20260112701-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY INCLUDING NONAQUEOUS ELECTROLYTIC SOLUTION | MU IONIC SOLUTIONS CORPORATION (JP) | 2026-04-23 | — | — | US | disclosed |
| US-20260081225-A1 | ELECTROLYTIC SOLUTION AND BATTERY | Guangzhou Tinci Materials Technology Co., Ltd (CN) | 2026-03-19 | — | — | US | disclosed |
| US-20090325065-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
| US-20090017386-A1 | Non-Aqueous Electrolytic Solutions And Electrochemical Cells Comprising The Same | FERRO CORPORATION (US) | 2009-01-15 | — | — | US | disclosed |
| WO-2009009251-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTIONS AND ELECTROCHEMICAL CELLS COMPRISING THE SAME | FERRO CORPORATION (US) | 2009-01-15 | — | — | WO | disclosed |
| EP-2012386-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260112701-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY INCLUDING NONAQUEOUS ELECTROLYTIC SOLUTION | NHERF1, SLC9A2, SCNN1B | CA2 76/4885CA1 225/4885CA7 254/4885 |
| US-20260081225-A1 | ELECTROLYTIC SOLUTION AND BATTERY | HCN1, HCN2, HCN3 | CA2 46/4885CA1 120/4885CA7 160/4885 |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | ASH2L, OLA1, ODC1 | CA2 32/4885CA1 167/4885CA7 122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.